Literature DB >> 2815255

The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.

R A Bray1, L K Lebeck, H M Gebel.   

Abstract

The flow cytometric crossmatch (FCXM) has become an increasingly utilized method to detect low levels of anti-donor antibodies (e.g., anti-HLA) in potential renal allograft recipients. Anti-donor antibodies not apparent in the standard complement-dependent crossmatch, but detectable by the FCXM, are often associated with increased episodes of graft rejection and early graft failure. In this study we examined several parameters of the FCXM in order to establish a standardized methodology. First, we observed that optimal staining results were obtained when the secondary antibody was an Fc-specific F(ab'), anti-human IgG. In contrast to an anti-whole immunoglobulin antibody, the anti-Fc specific reagent did not react with surface immunoglobulin on B cells but was reactive with cytophilic immunoglobulin present on CD16+ cells. Next we determined that dualcolor analysis was superior to single-color analysis both for the evaluation of T cell reactivities and for the discrimination of T cell from B cell reactivities. Additionally, dual-color analysis revealed that the density of class I histocompatibility antigens on B cells is greater than on T cells, indicating that B cells may be a more sensitive target for detecting low levels of anti-class I antibodies. Finally, we determined that a shift in the mean fluorescence intensity of greater than 10 channels on a 256-channel, 3-decade log scale was indicative of a positive FCXM. The data presented in these studies provide the basis for performing standardized dual-color FCXM with increased sensitivity and specificity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2815255

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients.

Authors:  Hong Xu; Paula M Chilton; Michael K Tanner; Yiming Huang; Carrie L Schanie; Mariano Dy-Liacco; Jun Yan; Suzanne T Ildstad
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

2.  HLA sensitization in islet transplantation.

Authors:  Michael R Rickels; Jane Kearns; Eileen Markmann; Maral Palanjian; James F Markmann; Ali Naji; Malek Kamoun
Journal:  Clin Transpl       Date:  2006

3.  Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.

Authors:  N A Turgeon; J G Avila; J A Cano; J J Hutchinson; I R Badell; A J Page; A B Adams; M H Sears; P H Bowen; A D Kirk; T C Pearson; C P Larsen
Journal:  Am J Transplant       Date:  2010-09       Impact factor: 8.086

4.  Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.

Authors:  Shane M Meehan; Joseph Kremer; Farah N Ali; Jessica Curley; Susana Marino; Anthony Chang; Pradeep V Kadambi
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-21       Impact factor: 8.237

5.  Single dose of alemtuzumab induction with steroid-free maintenance immunosuppression in pancreas transplantation.

Authors:  Tadahiro Uemura; Varun Ramprasad; Kazuhide Matsushima; Hiroko Shike; Tracy Valania; Osun Kwon; Nasrollah Ghahramani; Riaz Shah; Umar Farooq; Akhtar Khan; Zakiyah Kadry
Journal:  Transplantation       Date:  2011-09-27       Impact factor: 4.939

Review 6.  Human leukocyte antigen antibodies for monitoring transplant patients.

Authors:  Junchao Cai; Paul I Terasaki
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  Tailoring antibody testing and how to use it in the calculated panel reactive antibody era: the Northwestern University experience.

Authors:  Anat R Tambur; Joseph Leventhal; Dixon B Kaufman; John Friedewald; Joshua Miller; Michael M Abecassis
Journal:  Transplantation       Date:  2008-10-27       Impact factor: 4.939

8.  Genomic biomarkers correlate with HLA-identical renal transplant tolerance.

Authors:  Joseph R Leventhal; James M Mathew; Daniel R Salomon; Sunil M Kurian; Manikkam Suthanthiran; Anat Tambur; John Friedewald; Lorenzo Gallon; Jane Charette; Josh Levitsky; Yashpal Kanwar; Michael Abecassis; Joshua Miller
Journal:  J Am Soc Nephrol       Date:  2013-06-20       Impact factor: 10.121

9.  Technical and clinical aspects of the histocompatibility crossmatch assay in solid organ transplantation

Authors:  Ana María Arrunátegui; Daniel S Ramón; Luz Marina Viola; Linda G Olsen; Andrés Jaramillo
Journal:  Biomedica       Date:  2022-06-01       Impact factor: 1.173

10.  A new flow cytometry assay identifies recipient IgG subtype antibodies binding donor cells: increasing donor availability for highly sensitised patients.

Authors:  Prakash N Rao; Dayanand D Deo; Amitabh Gaur; David A Baran; Mark J Zucker; Saurabh Kapoor; Misty A Marchioni; Jesus Almendral; Praveen Kandula; Anup Patel
Journal:  Clin Transl Immunology       Date:  2022-09-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.